신경퇴행 질환에서 확장된 혈관주위공간의 임상 의의
Clinical Relevance of Enlarged Perivascular Spaces in Neurodegenerative Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Enlarged perivascular space (ePVS) is recently reported to be associated with cerebral small vessel disease (SVD) and Alzheimer’s disease (AD). The topographical location of ePVS may relate to the underlying pathology; basal ganglia (BG)-ePVS has been associated with cerebral vascular diseases and centrum semi-ovale (CSO)-ePVS associated with cerebral amyloid angiopathy (CAA). However, the effects of ePVS on various neurological conditions remain still controversial. To investigate the clinical relevance of ePVS in neurodegenerative diseases, we tested relationships between ePVS and cognition, markers of SVD, vascular risk factors, or amyloid pathology. Methods: We retrospectively reviewed 292 patients (133 AD dementia, 106 mild cognitive impairment, 39 other neurodegenerative diseases, 14 subjective cognitive decline) who underwent both amyloid positron emission tomography and brain magnetic resonance imaging. Vascular risk factors and cognitive tests results were collected. The ePVS in the BG and CSO, SVD markers and the volume of white matter hyperintensities were measured. Results: There were no significant differences in the severity and distribution of ePVS among clinical syndromes. Both BG- and CSO-ePVS were not related to cognitive function. Patients with lacunes were more likely to have high-degree BG-ePVS. High degree CSO-ePVS had an odds ratio (OR) for amyloid positive of 2.351, while BG-ePVS was a negative predictor for amyloid pathology (OR, 0.336). Conclusions: Our findings support that ePVS has different underlying pathologies according to the cerebral topography. BG-ePVS would be attributed to hypertensive angiopathy considering the relation with SVD markers, whereas and CSO-ePVS would be attributed to CAA considering the association with amyloid pathology.
Abstract
Background: Enlarged perivascular space (ePVS) is recently reported to be associated with cerebral small vessel disease (SVD) and Alzheimer’s disease (AD). The topographical location of ePVS may relate to the underlying pathology; basal ganglia (BG)-ePVS has been associated with cerebral vascular diseases and centrum semi-ovale (CSO)-ePVS associated with cerebral amyloid angiopathy (CAA). However, the effects of ePVS on various neurological conditions remain still controversial. To investigate the clinical relevance of ePVS in neurodegenerative diseases, we tested relationships between ePVS and cognition, markers of SVD, vascular risk factors, or amyloid pathology. Methods: We retrospectively reviewed 292 patients (133 AD dementia, 106 mild cognitive impairment, 39 other neurodegenerative diseases, 14 subjective cognitive decline) who underwent both amyloid positron emission tomography and brain magnetic resonance imaging. Vascular risk factors and cognitive tests results were collected. The ePVS in the BG and CSO, SVD markers and the volume of white matter hyperintensities were measured. Results: There were no significant differences in the severity and distribution of ePVS among clinical syndromes. Both BG- and CSO-ePVS were not related to cognitive function. Patients with lacunes were more likely to have high-degree BG-ePVS. High degree CSO-ePVS had an odds ratio (OR) for amyloid positive of 2.351, while BG-ePVS was a negative predictor for amyloid pathology (OR, 0.336). Conclusions: Our findings support that ePVS has different underlying pathologies according to the cerebral topography. BG-ePVS would be attributed to hypertensive angiopathy considering the relation with SVD markers, whereas and CSO-ePVS would be attributed to CAA considering the association with amyloid pathology.
참고문헌 (46)
- Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
- Jessen NA, "The glymphatic system : a beginner’s guide", Neurochem Res, 40, pp.2583~2599 (2015)
- Rasmussen MK, "The glymphatic pathway in neurological disorders", Lancet Neurol, 17, pp.1016~1024 (2018)
- Wardlaw JM, "Perivascular spaces in the brain : anatomy, physiology and pathology", Nat Rev Neurol, 16, pp.137~153 (2020)
- Yao M, "Hippocampal perivascular spaces are related to aging and blood pressure but not to cognition", Neurobiol Aging, 35, pp.2118~2125 (2014)
- Na HK, "Role of enlarged perivascular space in the temporal lobe in cerebral amyloidosis", Ann Neurol, 93, pp.965~978 (2023)
- Mortensen KN, "Impaired glymphatic transport in spontaneously hypertensive rats", J Neurosci, 39, pp.6365~6377 (2019)
- Maggi P, "The formation of inflammatory demyelinated lesions in cerebral white matter", Ann Neurol, 76, pp.594~608 (2014)
- Perosa V, "Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex", Acta Neuropathol, 143, pp.331~348 (2022)
- Doubal FN, "Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease", Stroke, 41, pp.450~454 (2010)
- 임영희, "늘어난 혈관주위공간: 노화와 신경계질환에서의 임상적의의와 영상의 역할", 대한영상의학회지, 83(3), pp.538~558 (2022), 대한영상의학회
- Alzheimer A, "An English translation of Alzheimer’s 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde"", Clin Anat, 8, pp.429~431 (1995)
- Ramirez J, "Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer’s disease patients and normal elderly from the Sunnybrook dementia study", J Alzheimers Dis, 43, pp.415~424 (2015)
- Banerjee G, "MRI-visible perivascular space location is associated with Alzheimer’s disease independently of amyloid burden", Brain, 140, pp.1107~1116 (2017)
- Kim HJ, "MRI-visible perivascular spaces in the centrum semiovale are associated with brain amyloid deposition in patients with Alzheimer disease-related cognitive impairment", AJNR Am J Neuroradiol, 42, pp.1231~1238 (2021)
- Shams S, "Topography and determinants of magnetic resonance imaging(MRI)-visible perivascular spaces in a large memory clinic cohort", J Am Heart Assoc, 6, pp.e006279~ (2017)
- Gertje EC, "Association of enlarged perivascular spaces and measures of small vessel and Alzheimer disease", Neurology, 96, pp.e193~e202 (2021)
- Wang ML, "Association of enlarged perivascular spaces with Aβ and tau deposition in cognitively normal older population", Neurobiol Aging, 100, pp.32~38 (2021)
- Vilor-Tejedor N, "Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum", Alzheimers Res Ther, 13, pp.135~ (2021)
- Passiak BS, "Perivascular spaces contribute to cognition beyond other small vessel disease markers", Neurology, 92, pp.e1309~e1321 (2019)
- Paradise M, "Association of dilated perivascular spaces with cognitive decline and incident dementia", Neurology, 96, pp.e1501~e1511 (2021)
- Hilal S, "Enlarged perivascular spaces and cognition : a meta-analysis of 5 population-based studies", Neurology, 91, pp.e832~e842 (2018)
- Choe YM, "Association between enlarged perivascular spaces and cognition in a memory clinic population", Neurology, 99, pp.e1414~e1421 (2022)
- McKhann GM, "The diagnosis of dementia due to Alzheimer’s disease : recommendations from the National Institute on AgingAlzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.263~269 (2011)
- Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.270~279 (2011)
- Petersen RC, "Mild cognitive impairment : clinical characterization and outcome", Arch Neurol, 56, pp.303~308 (1999)
- Jessen F, "A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease", Alzheimers Dement, 10, pp.844~852 (2014)
- Neary D, "Frontotemporal lobar degeneration : a consensus on clinical diagnostic criteria", Neurology, 51, pp.1546~1554 (1998)
- McKeith IG, "Diagnosis and management of dementia with Lewy bodies : fourth consensus report of the DLB consortium", Neurology, 89, pp.88~100 (2017)
- Postuma RB, "MDS clinical diagnostic criteria for Parkinson’s disease", Mov Disord, 30, pp.1591~1601 (2015)
- Wenning GK, "The movement disorder society criteria for the diagnosis of multiple system atrophy", Mov Disord, 37, pp.1131~1148 (2022)
- Höglinger GU, "Clinical diagnosis of progressive supranuclear palsy : the movement disorder society criteria", Mov Disord, 32, pp.853~864 (2017)
- Armstrong MJ, "Criteria for the diagnosis of corticobasal degeneration", Neurology, 80, pp.496~503 (2013)
- Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
- Maclullich AM, "Enlarged perivascular spaces are associated with cognitive function in healthy elderly men", J Neurol Neurosurg Psychiatry, 75, pp.1519~1523 (2004)
- Martinez-Ramirez S, "Topography of dilated perivascular spaces in subjects from a memory clinic cohort", Neurology, 80, pp.1551~1556 (2013)
- Benjamin P, "Lacunar infarcts, but not perivascular spaces, are predictors of cognitive decline in cerebral small-vessel disease", Stroke, 49, pp.586~593 (2018)
- Cordonnier C, "Improving interrater agreement about brain microbleeds : development of the brain observer microbleed scale(BOMBS)", Stroke, 40, pp.94~99 (2009)
- Schmidt P, "An automated tool for detection of FLAIR-hyperintense whitematter lesions in multiple sclerosis", Neuroimage, 59, pp.3774~3783 (2012)
- flutemetamol PET images can detect early amyloid pathology and grade its extent, "Eur J Nucl Med Mol Imaging", 2021, 2169~2182
- Kang Y, "Seoul Neuropsychological Screening Battery" (2003), Human Brain Research & Consulting
- Ryu Hui Jin, "The Seoul Neuropsychological Screening Battery (SNSB) for Comprehensive Neuropsychological Assessment", Dementia and Neurocognitive Disorders(대한치매학회지), 22(1), pp.1~15 (2023), 대한치매학회[DOI]
- Passiak BS, "Perivascular spaces contribute to cognition beyond other small vessel disease markers", Neurology, 92, pp.e1309~e1321 (2019)
- Jeong SH, "Association of enlarged perivascular spaces with amyloid burden and cognitive decline in Alzheimer disease continuum", Neurology, 99, pp.e1791~e1802 (2022)
- Adams HH, "A priori collaboration in population imaging : the uniform neuro-imaging of Virchow-Robin spaces enlargement consortium", Alzheimers Dement(Amst), 1, pp.513~520 (2015)
- Kim KH, "Comparison of amyloid in cerebrospinal fluid, brain imaging, and autopsy in a case of progressive supranuclear palsy", Alzheimer Dis Assoc Disord, 34, pp.275~277 (2020)